Powered by MRP Announces Exclusive Agreement with LUVO Medical

To Distribute Aesthetic Devices in the United States

MRP.io (“MRP”) announced today that it has signed an exclusive agreement with LUVO Medical, headquartered in Ontario, Canada, for the sale and distribution of four LUVO products in the United States – the Bare 808, Bela MD+ Advanced Skin Health Platform, the Darwin and the Lucent IPL.

MRP founder and CEO Scott Carson stated, “This partnership is an amazing opportunity for Powered by MRP to get LUVO Medical products into the hands of clinicians in the United States for the first time.”

Modifying the aesthetics marketplace through successful sales and guarantees of pre-owned equipment, MRP has continued to expand its catalog of new equipment sales and distribution from manufacturers, including its latest venture with LUVO Medical.

“We are thrilled to partner with MRP for the exclusive sale of four LUVO devices in the United States,” said Kevin Noseworthy, VP of Sales at LUVO medical. “With the Bela MD+ Advanced Skin Health Platform being one of the most sought-after products for 2022, this couldn’t have come at a better time for LUVO Medical and MRP.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version